Business News • PR NewsWire • Anaeropharma Science Signs Collaborative Research Agreement with Astellas on Creation of Novel Anti-Tumor Drugs Using Bifidobacterium

Anaeropharma Science Signs Collaborative Research Agreement with Astellas on Creation of Novel Anti-Tumor Drugs Using Bifidobacterium

Anaeropharma Science Signs Collaborative Research Agreement with Astellas on Creation of Novel Anti-Tumor Drugs Using Bifidobacterium

TOKYO, Sept. 25, 2018 /PRNewswire/ -- Anaeropharma Science Inc. headquartered in Tokyo (hereafter "Anaeropharma") announced on September 25 that Anaeropharma and Astellas Pharma Inc. headquartered in Tokyo (hereafter "Astellas") have concluded a collaborative research agreement concerning ...

View More : https://www.prnewswire.com:443/news-releases/anaeropharma-science-signs-collaborative-research-agreement-with-astellas-o...

Releted News by prnewswire

CommerceWest Bank Partnered with WHW, Formerly Known as Women Helping Women

Atox Bio Announces Independent Safety Monitoring Committee Recommendation to Continue Phase 3 Study of Reltecimod in Necrotizing Soft Tissue Infections

Holmusk Raises US$9.75 Million in Pre-Series A Financing